{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T10:16:26Z","timestamp":1742638586207,"version":"3.37.3"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T00:00:00Z","timestamp":1472256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T00:00:00Z","timestamp":1472256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Medical Research Scholars Program"],"award-info":[{"award-number":["Medical Research Scholars Program"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s11060-016-2240-8","type":"journal-article","created":{"date-parts":[[2016,8,27]],"date-time":"2016-08-27T06:59:12Z","timestamp":1472281152000},"page":"111-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["ZEB1 expression is increased in IDH1-mutant lower-grade gliomas"],"prefix":"10.1007","volume":"130","author":[{"given":"Cody L.","family":"Nesvick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blake K.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunzhang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsha J.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhik","family":"Ray-Chaudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengping","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,8,27]]},"reference":[{"key":"2240_CR1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","volume":"359","author":"PY Wen","year":"2008","unstructured":"Wen PY, Kesari S (2008) Malignant gliomas in adults. N Engl J Med 359:492\u2013507","journal-title":"N Engl J Med"},{"issue":"19","key":"2240_CR2","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1158\/1538-7445.AM2014-936","volume":"74","author":"RG Verhaak","year":"2014","unstructured":"Verhaak RG, Cooper LA, Salama SS, Aldape K, Yung WA, Brat DJ (2014) Comprehensive and integrative genomic characterization of diffuse lower grade gliomas. Cancer Res 74(19):936","journal-title":"Cancer Res"},{"issue":"3","key":"2240_CR3","doi-asserted-by":"publisher","first-page":"iii3","DOI":"10.1093\/neuonc\/nou206.11","volume":"16","author":"DJ Brat","year":"2014","unstructured":"Brat DJ, TCGA Lower Grade Gliomas Analysis Working Group (2014) Integrative genomic characterization of lower grade gliomas. Neuro-oncology 16(suppl 3):iii3","journal-title":"Neuro-oncology"},{"key":"2240_CR4","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1056\/NEJMoa1402121","volume":"372","author":"DJ Brat","year":"2015","unstructured":"Cancer Genome Atlas Research Network, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M et al (2015) Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med 372:2481\u20132498","journal-title":"N Engl J Med"},{"key":"2240_CR5","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV et al (2015) Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372:2499\u20132508","journal-title":"N Engl J Med"},{"key":"2240_CR6","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"H Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765\u2013773","journal-title":"N Engl J Med"},{"key":"2240_CR7","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807\u20131812","journal-title":"Science"},{"key":"2240_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17:98\u2013110","journal-title":"Cancer Cell"},{"key":"2240_CR9","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420\u20131428","journal-title":"J Clin Invest"},{"key":"2240_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M et al (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133:704\u2013715","journal-title":"Cell"},{"key":"2240_CR11","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/ncb1998","volume":"11","author":"U Wellner","year":"2009","unstructured":"Wellner U, Schubert J, Burk UC, Schmalhofer O, Zhu F, Sonntag A, Waldvogel B, Vannier C, Darling D, zur Hausen A et al (2009) The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11:1487\u20131495","journal-title":"Nat Cell Biol"},{"key":"2240_CR12","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/ncb1722","volume":"10","author":"PA Gregory","year":"2008","unstructured":"Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10:593\u2013601","journal-title":"Nat Cell Biol"},{"key":"2240_CR13","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/jnci\/djr224","volume":"103","author":"LA Edwards","year":"2011","unstructured":"Edwards LA, Woolard K, Son MJ, Li A, Lee J, Ene C, Mantey SA, Maric D, Song H, Belova G et al (2011) Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion. J Natl Cancer Inst 103:1162\u20131178","journal-title":"J Natl Cancer Inst"},{"key":"2240_CR14","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1593\/neo.04352","volume":"7","author":"MC Elias","year":"2005","unstructured":"Elias MC, Tozer KR, Silber JR, Mikheeva S, Deng M, Morrison RS, Manning TC, Silbergeld DL, Glackin CA, Reh TA et al (2005) TWIST is expressed in human gliomas and promotes invasion. Neoplasia 7:824\u2013837","journal-title":"Neoplasia"},{"key":"2240_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10571-010-9643-4","volume":"31","author":"SP Han","year":"2011","unstructured":"Han SP, Kim JH, Han ME, Sim HE, Kim KS, Yoon S, Baek SY, Kim BS, Oh SO (2011) SNAI1 is involved in the proliferation and migration of glioblastoma cells. Cell Mol Neurobiol 31:489\u2013496","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"2240_CR16","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/bpa.12240","volume":"25","author":"U Kahlert","year":"2014","unstructured":"Kahlert U, Suwala A, Raabe E, Siebzehnrubl F, Suarez M, Orr B, Bar E, Maciaczyk J, Eberhart C (2014) ZEB1 Promotes invasion in human fetal neural stem cells and hypoxic glioma neurospheres. Brain Pathol 25(6):724\u2013732","journal-title":"Brain Pathol"},{"key":"2240_CR17","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/emmm.201302827","volume":"5","author":"FA Siebzehnrubl","year":"2013","unstructured":"Siebzehnrubl FA, Silver DJ, Tugertimur B, Deleyrolle LP, Siebzehnrubl D, Sarkisian MR, Devers KG, Yachnis AT, Kupper MD, Neal D et al (2013) The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med 5:1196\u20131212","journal-title":"EMBO Mol Med"},{"key":"2240_CR18","doi-asserted-by":"publisher","first-page":"8914","DOI":"10.18632\/oncotarget.3563","volume":"6","author":"H Liao","year":"2015","unstructured":"Liao H, Bai Y, Qiu S, Zheng L, Huang L, Liu T, Wang X, Liu Y, Xu N, Yan X et al (2015) MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2. Oncotarget 6:8914\u20138928","journal-title":"Oncotarget"},{"key":"2240_CR19","doi-asserted-by":"publisher","first-page":"e38842","DOI":"10.1371\/journal.pone.0038842","volume":"7","author":"S Qi","year":"2012","unstructured":"Qi S, Song Y, Peng Y, Wang H, Long H, Yu X, Li Z, Fang L, Wu A, Luo W et al (2012) ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma. PLoS One 7:e38842","journal-title":"PLoS One"},{"key":"2240_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11060-009-0015-1","volume":"97","author":"M Xia","year":"2010","unstructured":"Xia M, Hu M, Wang J, Xu Y, Chen X, Ma Y, Su L (2010) Identification of the role of Smad interacting protein 1 (SIP1) in glioma. J Neurooncol 97:225\u2013232","journal-title":"J Neurooncol"},{"key":"2240_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/1471-2407-10-301","volume":"10","author":"HW Yang","year":"2010","unstructured":"Yang HW, Menon LG, Black PM, Carroll RS, Johnson MD (2010) SNAI2\/Slug promotes growth and invasion in human gliomas. BMC Cancer 10:301","journal-title":"BMC Cancer"},{"key":"2240_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6:1\u20136","journal-title":"Neoplasia"},{"key":"2240_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1158\/1541-7786.MCR-08-0435","volume":"7","author":"S Madhavan","year":"2009","unstructured":"Madhavan S, Zenklusen JC, Kotliarov Y, Sahni H, Fine HA, Buetow K (2009) Rembrandt: helping personalized medicine become a reality through integrative translational research. Mol Cancer Res 7:157\u2013167","journal-title":"Mol Cancer Res"},{"key":"2240_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401\u2013404","journal-title":"Cancer Discov"},{"key":"2240_CR25","doi-asserted-by":"publisher","first-page":"8679","DOI":"10.1158\/0008-5472.CAN-05-1204","volume":"65","author":"M Bredel","year":"2005","unstructured":"Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, Recht LD, Sikic BI (2005) Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res 65:8679\u20138689","journal-title":"Cancer Res"},{"key":"2240_CR26","doi-asserted-by":"publisher","first-page":"11335","DOI":"10.1158\/0008-5472.CAN-05-1886","volume":"65","author":"PJ French","year":"2005","unstructured":"French PJ, Swagemakers SM, Nagel JH, Kouwenhoven MC, Brouwer E, van der Spek P, Luider, Kros JM, van den Bent MJ, Sillevis Smitt PA (2005) Gene expression profiles associated with treatment response in oligodendrogliomas. Cancer Res 65:11335\u201311344","journal-title":"Cancer Res"},{"key":"2240_CR27","doi-asserted-by":"publisher","first-page":"5814","DOI":"10.1073\/pnas.0402870102","volume":"102","author":"Y Liang","year":"2005","unstructured":"Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, Lamborn KR, Berger MS, Botstein D, Brown PO et al (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci USA 102:5814\u20135819","journal-title":"Proc Natl Acad Sci USA"},{"key":"2240_CR28","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1038\/sj.onc.1206753","volume":"22","author":"R Shai","year":"2003","unstructured":"Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, Mischel PS, Nelson SF (2003) Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 22:4918\u20134923","journal-title":"Oncogene"},{"key":"2240_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ccr.2006.03.003","volume":"9","author":"L Sun","year":"2006","unstructured":"Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R et al (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9:287\u2013300","journal-title":"Cancer Cell"},{"key":"2240_CR30","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.2353\/ajpath.2009.080958","volume":"174","author":"T Watanabe","year":"2009","unstructured":"Watanabe T, Nobusawa S, Kleihues P, Ohgaki H (2009) IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol 174:1149\u20131153","journal-title":"Am J Pathol"},{"key":"2240_CR31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00401-012-1031-3","volume":"124","author":"XY Liu","year":"2012","unstructured":"Liu XY, Gerges N, Korshunov A, Sabha N, Khuong-Quang DA, Fontebasso AM, Fleming A, Hadjadj D, Schwartzentruber J, Majewski J et al (2012) Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1\/IDH2 and TP53 mutations. Acta Neuropathol (Berl) 124:615\u2013625","journal-title":"Acta Neuropathol (Berl)"},{"key":"2240_CR32","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1126\/science.1210557","volume":"333","author":"C Bettegowda","year":"2011","unstructured":"Bettegowda C, Agrawal N, Jiao Y, Sausen M, Wood LD, Hruban RH, Rodriguez FJ, Cahill DP, McLendon R, Riggins G et al (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333:1453\u20131455","journal-title":"Science"},{"key":"2240_CR33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00401-012-0993-5","volume":"123","author":"F Sahm","year":"2012","unstructured":"Sahm F, Koelsche C, Meyer J, Pusch S, Lindenberg K, Mueller W, Herold-Mende C, von Deimling A, Hartmann C (2012) CIC and FUBP1 mutations in oligodendrogliomas, oligoastrocytomas and astrocytomas. Acta Neuropathol (Berl) 123:853\u2013860","journal-title":"Acta Neuropathol (Berl)"},{"key":"2240_CR34","doi-asserted-by":"publisher","first-page":"42180","DOI":"10.1074\/jbc.M112.417832","volume":"287","author":"AR Grassian","year":"2012","unstructured":"Grassian AR, Lin F, Barrett R, Liu Y, Jiang W, Korpal M, Astley H, Gitterman D, Henley T, Howes R et al (2012) Isocitrate dehydrogenase (IDH) mutations promote a reversible ZEB1\/microRNA (miR)-200-dependent epithelial-mesenchymal transition (EMT). J Biol Chem 287:42180\u201342194","journal-title":"J Biol Chem"},{"key":"2240_CR35","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.1038\/sj.onc.1210508","volume":"26","author":"K Aigner","year":"2007","unstructured":"Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist P et al (2007) The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26:6979\u20136988","journal-title":"Oncogene"},{"key":"2240_CR36","doi-asserted-by":"publisher","first-page":"11572","DOI":"10.1074\/jbc.M112.434951","volume":"288","author":"Y Liu","year":"2013","unstructured":"Liu Y, Sanchez-Tillo E, Lu X, Huang L, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A et al (2013) Sequential inductions of the ZEB1 transcription factor caused by mutation of Rb and then Ras proteins are required for tumor initiation and progression. J Biol Chem 288:11572\u201311580","journal-title":"J Biol Chem"},{"key":"2240_CR37","doi-asserted-by":"publisher","first-page":"4116","DOI":"10.1074\/jbc.M113.533505","volume":"289","author":"Y Liu","year":"2014","unstructured":"Liu Y, Sanchez-Tillo E, Lu X, Huang L, Clem B, Telang S, Jenson AB, Cuatrecasas M, Chesney J, Postigo A et al (2014) The ZEB1 transcription factor acts in a negative feedback loop with miR200 downstream of Ras and Rb1 to regulate Bmi1 expression. J Biol Chem 289:4116\u20134125","journal-title":"J Biol Chem"},{"key":"2240_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cell.2013.06.005","volume":"154","author":"CL Chaffer","year":"2013","unstructured":"Chaffer CL, Marjanovic ND, Lee T, Bell G, Kleer CG, Reinhardt F, D\u2019Alessio AC, Young RA, Weinberg RA (2013) Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity. Cell 154:61\u201374","journal-title":"Cell"},{"key":"2240_CR39","doi-asserted-by":"publisher","first-page":"5660","DOI":"10.1038\/ncomms6660","volume":"5","author":"Y Liu","year":"2014","unstructured":"Liu Y, Lu X, Huang L, Wang W, Jiang G, Dean KC, Clem B, Telang S, Jenson AB, Cuatrecasas M et al (2014) Different thresholds of ZEB1 are required for Ras-mediated tumour initiation and metastasis. Nature Commun 5:5660","journal-title":"Nature Commun"},{"key":"2240_CR40","doi-asserted-by":"publisher","first-page":"e102927","DOI":"10.1371\/journal.pone.0102927","volume":"9","author":"E Serna","year":"2014","unstructured":"Serna E, Lopez-Gines C, Monleon D, Munoz-Hidalgo L, Callaghan RC, Gil-Benso R, Martinetto H, Gregori-Romero A, Gonzalez-Darder J, Cerda-Nicolas M (2014) Correlation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme. PLoS One 9:e102927","journal-title":"PLoS One"},{"key":"2240_CR41","doi-asserted-by":"publisher","first-page":"e1443","DOI":"10.1038\/cddis.2014.395","volume":"5","author":"JV Joseph","year":"2014","unstructured":"Joseph JV, Conroy S, Tomar T, Eggens-Meijer E, Bhat K, Copray S, Walenkamp AM, Boddeke E, Balasubramanyian V, Wagemakers M et al (2014) TGF-beta is an inducer of ZEB1-dependent mesenchymal transdifferentiation in glioblastoma that is associated with tumor invasion. Cell Death Dis 5:e1443","journal-title":"Cell Death Dis"},{"key":"2240_CR42","doi-asserted-by":"publisher","first-page":"19204","DOI":"10.1073\/pnas.1108977108","volume":"108","author":"E Sanchez-Tillo","year":"2011","unstructured":"Sanchez-Tillo E, de Barrios O, Siles L, Cuatrecasas M, Castells A, Postigo A (2011) Beta-catenin\/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci USA 108:19204\u201319209","journal-title":"Proc Natl Acad Sci USA"},{"key":"2240_CR43","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/j.cellsig.2012.08.004","volume":"24","author":"K Wu","year":"2012","unstructured":"Wu K, Fan J, Zhang L, Ning Z, Zeng J, Zhou J, Li L, Chen Y, Zhang T, Wang X et al (2012) PI3K\/Akt to GSK3beta\/beta-catenin signaling cascade coordinates cell colonization for bladder cancer bone metastasis through regulating ZEB1 transcription. Cell Signal 24:2273\u20132282","journal-title":"Cell Signal"},{"key":"2240_CR44","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1038\/onc.2013.492","volume":"33","author":"X Sun","year":"2014","unstructured":"Sun X, Jiao X, Pestell TG, Fan C, Qin S, Mirabelli E, Ren H, Pestell RG (2014) MicroRNAs and cancer stem cells: the sword and the shield. Oncogene 33:4967\u20134977","journal-title":"Oncogene"},{"key":"2240_CR45","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1093\/neuonc\/nos145","volume":"14","author":"X Ma","year":"2012","unstructured":"Ma X, Yoshimoto K, Guan Y, Hata N, Mizoguchi M, Sagata N, Murata H, Kuga D, Amano T, Nakamizo A et al (2012) Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma. Neuro Oncol 14:1153\u20131162","journal-title":"Neuro Oncol"},{"key":"2240_CR46","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"L Dang","year":"2009","unstructured":"Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC et al (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739\u2013744","journal-title":"Nature"},{"key":"2240_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","volume":"17","author":"PS Ward","year":"2010","unstructured":"Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE et al (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17:225\u2013234","journal-title":"Cancer Cell"},{"key":"2240_CR48","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature10860","volume":"483","author":"C Lu","year":"2012","unstructured":"Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A et al (2012) IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483:474\u2013478","journal-title":"Nature"},{"key":"2240_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"W Xu","year":"2011","unstructured":"Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, Ito S, Yang C, Wang P, Xiao MT et al (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17\u201330","journal-title":"Cancer Cell"},{"key":"2240_CR50","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1126\/science.1231677","volume":"339","author":"JA Losman","year":"2013","unstructured":"Losman JA, Looper RE, Koivunen P, Lee S, Schneider RK, McMahon C, Cowley GS, Root DE, Ebert BL, Kaelin WG Jr (2013) (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339:1621\u20131625","journal-title":"Science"},{"key":"2240_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0169-328X(01)00267-4","volume":"96","author":"G Yen","year":"2001","unstructured":"Yen G, Croci A, Dowling A, Zhang S, Zoeller RT, Darling DS (2001) Developmental and functional evidence of a role for Zfhep in neural cell development. Brain Res Mol Brain Res 96:59\u201367","journal-title":"Brain Res Mol Brain Res"},{"key":"2240_CR52","doi-asserted-by":"publisher","first-page":"e4373","DOI":"10.1371\/journal.pone.0004373","volume":"4","author":"T Bui","year":"2009","unstructured":"Bui T, Sequeira J, Wen TC, Sola A, Higashi Y, Kondoh H, Genetta T (2009) ZEB1 links p63 and p73 in a novel neuronal survival pathway rapidly induced in response to cortical ischemia. PLoS One 4:e4373","journal-title":"PLoS One"},{"key":"2240_CR53","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1002\/stem.226","volume":"27","author":"JC Sabourin","year":"2009","unstructured":"Sabourin JC, Ackema KB, Ohayon D, Guichet PO, Perrin FE, Garces A, Ripoll C, Charite J, Simonneau L, Kettenmann H et al (2009) A mesenchymal-like ZEB1(+) niche harbors dorsal radial glial fibrillary acidic protein-positive stem cells in the spinal cord. Stem Cells 27:2722\u20132733","journal-title":"Stem Cells"},{"key":"2240_CR54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1126\/science.1170944","volume":"324","author":"S Zhao","year":"2009","unstructured":"Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, Yu W, Li Z, Gong L, Peng Y et al (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324:261\u2013265","journal-title":"Science"},{"key":"2240_CR55","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature10898","volume":"483","author":"P Koivunen","year":"2012","unstructured":"Koivunen P, Lee S, Duncan CG, Lopez G, Lu G, Ramkissoon S, Losman JA, Joensuu P, Bergmann U, Gross S et al (2012) Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483:484\u2013488","journal-title":"Nature"},{"key":"2240_CR56","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/ana.22390","volume":"69","author":"LB Bralten","year":"2011","unstructured":"Bralten LB, Kloosterhof NK, Balvers R, Sacchetti A, Lapre L, Lamfers M, Leenstra S, de Jonge H, Kros JM, Jansen EE et al (2011) IDH1 R132H decreases proliferation of glioma cell lines in vitro and in vivo. Ann Neurol 69:455\u2013463","journal-title":"Ann Neurol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2240-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-016-2240-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-016-2240-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T07:22:16Z","timestamp":1589700136000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-016-2240-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,27]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["2240"],"URL":"https:\/\/doi.org\/10.1007\/s11060-016-2240-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2016,8,27]]},"assertion":[{"value":"14 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no known conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}